Conmed/$CNMD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Conmed
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Geographically operates in USA, Europe, Middle East & Africa, Asia Pacific and North America. Majority is revenue is from USA.
Ticker
$CNMD
Sector
Primary listing
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Employees
3,900
ISIN
US2074101013
Website
Conmed Metrics
BasicAdvanced
$1.6B
13.73
$3.81
1.29
$0.80
1.53%
Price and volume
Market cap
$1.6B
Beta
1.29
52-week high
$75.43
52-week low
$46.00
Average daily volume
337K
Dividend rate
$0.80
Financial strength
Current ratio
2.257
Quick ratio
0.906
Long term debt to equity
91.184
Total debt to equity
98.387
Dividend payout ratio (TTM)
20.78%
Interest coverage (TTM)
4.43%
Profitability
EBITDA (TTM)
223.195
Gross margin (TTM)
56.02%
Net profit margin (TTM)
9.02%
Operating margin (TTM)
12.11%
Effective tax rate (TTM)
18.26%
Revenue per employee (TTM)
$340,000
Management effectiveness
Return on assets (TTM)
4.14%
Return on equity (TTM)
12.96%
Valuation
Price to earnings (TTM)
13.733
Price to revenue (TTM)
1.229
Price to book
1.66
Price to tangible book (TTM)
-3.5
Price to free cash flow (TTM)
9.827
Free cash flow yield (TTM)
10.18%
Free cash flow per share (TTM)
532.63%
Dividend yield (TTM)
1.53%
Forward dividend yield
1.53%
Growth
Revenue change (TTM)
4.32%
Earnings per share change (TTM)
46.38%
3-year revenue growth (CAGR)
8.85%
10-year revenue growth (CAGR)
5.98%
3-year earnings per share growth (CAGR)
22.08%
10-year earnings per share growth (CAGR)
13.44%
What the Analysts think about Conmed
Analyst ratings (Buy, Hold, Sell) for Conmed stock.
Bulls say / Bears say
CONMED reported a 4.0% year-over-year increase in Q3 2024 sales, reaching $316.7 million, indicating strong operational performance. (Business Wire)
Analysts have a consensus 'Moderate Buy' rating for CONMED, with an average 12-month price target of $79.80, suggesting potential upside from current levels. (MarketBeat)
The company's Orthopedic Surgery segment saw a 4.7% increase in sales during Q3 2024, driven by demand for sports medicine and BioBrace products, highlighting growth in key product lines. (BeyondSPX)
CONMED's stock price has declined approximately 45% from its 52-week high, reflecting potential investor concerns. (GuruFocus)
The company has a relatively high debt level, with $114.6 million in borrowings on the term loan facility and $36.0 million under the revolving credit facility, which could impact financial flexibility. (DCF.fm)
Some analysts have lowered their price targets for CONMED, with Piper Sandler reducing it from $95.00 to $80.00, indicating tempered expectations. (MarketBeat)
Data summarised monthly by Lightyear AI. Last updated on 5 Jun 2025.
Conmed Financial Performance
Revenues and expenses
Conmed Earnings Performance
Company profitability
Conmed News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Jul3
Conmed
Dividend·Payment
$0.20Per share
FAQs
What’s the current market cap for Conmed stock?
Conmed (CNMD) has a market cap of $1.6B as of June 27, 2025.
What is the P/E ratio for Conmed stock?
The price to earnings (P/E) ratio for Conmed (CNMD) stock is 13.73 as of June 27, 2025.
Does Conmed stock pay dividends?
Yes, the Conmed (CNMD) stock pays dividends to shareholders. As of June 27, 2025, the dividend rate is $0.8 and the yield is 1.53%. Conmed has a payout ratio of 20.78% on a trailing twelve-month basis.
When is the next Conmed dividend payment date?
The next Conmed (CNMD) dividend payment is scheduled for July 03, 2025.
What is the beta indicator for Conmed?
Conmed (CNMD) has a beta rating of 1.29. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.